Huntington's chorea (also known as St. Vitus' dance) is a rare brain disorder that causes, among other symptoms, uncontrollable, jerky movements in individuals. Photo: Getty Images/Science Photo ...

Huntington’s disease is a hereditary brain disorder that impacts movement, mood, and cognitive abilities. It gets worse over ...

SAN DIEGO, Oct. 6, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today presented new data from the open-label KINECT®-HD2 study demonstrating an established long-term safety profile ...

After years of heartbreak, researchers have found an experimental treatment that can slow the progression of Huntington’s ...

Researchers announce breakthrough results for AMT-130, the first disease-modifying treatment for Huntington's disease, with ...

Neurocrine Biosciences shows strong growth with rising INGREZZA sales, expanding pipeline, and solid financials despite key ...

As well as slowing disease progression by 75 percent at 36 months, the scientists found that neurofilament light protein (NfL)—a biomarker of neuronal damage—levels in spinal fluid were lower in ...

Sex influences how genetic and age-related factors translate into clinical and neuroimaging trajectories in Huntington disease.

Victor Sung, M.D., director of the Division of Movement Disorders in the University of Alabama at Birmingham Department of ...

In a small trial, a gene therapy injected into the brain slowed the disease by 75 percent over three years. Huntington’s disease is extremely cruel. Symptoms start with random, uncontrollable twitches ...

A new gene therapy has slowed the progression of Huntington's disease by as much as 75%. Known as AMT-130, it is delivered via brain surgery, and a single dose is expected to last someone's whole life ...